Transactions: Share issues and placements
Filter
Directed share issue in Inzile AB (SE) — SEK 127 million
Directed share issue in Paxman AB (SE) — SEK 60 million
Rights issue in InDex Pharmaceuticals Holding AB (SE) — SEK 533 million
Placing of shares in Boozt AB (SE) — SEK 1.0 billion
Directed share issue in Bambuser AB (SE) — SEK 500 million
Directed share issue in Bayn Group AB (SE) — SEK 81.2 million
Directed share issue in Novelda AS (NO) — NOK 100 million
Directed share issue in Cantargia AB (SE) — SEK 564 million
Directed share issue in PatientSky AS (NO) — NOK 350 million